Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: A systematic review

BMC Family Practice

Volumn 7, Issue , 2006, Pages

  Dyer, Matthew J ^a   Halpin, David M G ^b   Stein, Ken ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CICLESONIDE; FLUTICASONE PROPIONATE; ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; FLUTICASONE; PREGNANE DERIVATIVE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; LUNG FUNCTION; QUALITY OF LIFE; QUESTIONNAIRE; SYSTEMATIC REVIEW; CHRONIC DISEASE; INHALATIONAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADMINISTRATION, INHALATION; ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; BUDESONIDE; CHRONIC DISEASE; FLUTICASONE; HUMANS; PREGNENEDIONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33746665377     PISSN: 14712296     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-7-34     Document Type: Article

References (36)

1. Barnes PJ, Pedersen S: Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993, 148:S1-26.
2. British guideline on the management of asthma. Thorax 2003, 58 Suppl 1:i1-94.
3. Eccles M, Rousseau N, Higgins B, Thomas L: Evidence-based guideline on the primary care management of asthma. Fam Pract 2001, 18:223-229.
4. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics - 2002. J Allergy Clin Immunol 2002, 110:S141-S219.
5. Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. Lancet 2002, 360:1313-1322.
6. Allen DB, Bielory L, Derendorf H, Dluhy R, Colice GL, Szefler SJ: Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003, 112:S1-40.
7. Weinbrenner A, Huneke D, Zschiesche M, Engel G, Timmer W, Steinijans VW, Bethke T, Wurst W, Drollmann A, Kaatz HJ, Siegmund W: Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide. J Clin Endocrinol Metab 2002, 87:2160-2163.
8. Rohatagi S, Appajosyula S, Derendorf H, Szefler S, Nave R, Zech K, Banerji D: Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/ pharmacodynamic perspective. J Clin Pharmacol 2004, 44:37-47.
9. Jackson LD, Polygenis D, McIvor RA, Worthington I: Comparative efficacy and safety of inhaled corticosteroids in asthma. Can J Clin Pharmacol 1999, 6:26-37.
10. Adams N, Bestall JM, Lasserson TJ, Jones PW: Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma. Cochrane Database Syst Rev 2004:CD002310.
11. Compendium EM: Alvesco Product Information. Electronic Medicines Compendium 2005 [http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp? documentid=15768].
12. Belvisi MG: Preclinical pharmacology of ciclesonide. European Respiratory Review 2004, 13:66-68.
13. Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen BK, Barrett JS: Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol 2003, 43:365-378.
14. Nave R, Bethke TD, van Marle SP, Zech K: Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin Pharmacokinet 2004, 43:479-486.
15. Nave R, Zech K, Bethke TD: Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. Eur J Clin Pharmacol 2005.
16. Richter K, Kanniess F, Biberger C, Nave R, Magnussen H: Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma. J Clin Pharmacol 2005, 45:146-152.
17. Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ: Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest 2005, 127:851-860.
18. Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ: Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma. Br J Clin Pharmacol 2004, 58:26-33.
19. Kanniess F, Richter K, Bohme S, Jorres RA, Magnussen H: Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma. Pulm Pharmacol Ther 2001, 14:141-147.
20. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR: Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999, 14:32-38.
21. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P: The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992, 326:226-230.
22. Wolthers OD, Honour JW: Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications. J Asthma 1999, 36:477-486.
23. Hanania NA, Chapman KR, Kesten S: Adverse effects of inhaled corticosteroids. Am J Med 1995, 98:196-208.
24. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S: Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995, 96:571-579.
25. Barnes NC: Safety of high-dose inhaled corticosteroids. Respir Med 1993, 87 Suppl A:27-31.
26. Warrell DAE: Oxford Textbook of Medicine. 2003, 2:.
27. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ: Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers. Chest 2002, 122:510-516.
28. Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L: The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess 2005, 9:iii, xi-iii,230.
29. Boulet LP, Engelstatter R, Magyar P, Timar M, Knight A, Fabbri L: Ciclesonide is at least as effective as budesonide in the treatment of patients with bronchial asthma [abstract]. American Thoracic Society 99th International Conference 2003:C105.
30. Ukena D, Biberger C, Von BV, Malek R, Weber HH, Beck E, Linnhoff A: Ciclesonide significantly improves pulmonary function when compared with budesonide: a randomised 12 week study [Abstract]. European Respiratory Journal 2003, 22:.
31. Engelstatter R, Benezet O, Kafe H, Ponitz HH, Hansel T, Cheung D, Steinijans VW, Barnes PJ: Comparative study in asthma patients treated with inhaled ciclesonide (80µg or 320µg once daily) or budesonide (200µg twice daily) for 12 weeks [abstract]. American Thoracic Society 99th International Conference 2003:C105.
32. Biberger C, Von BV, Malek R, Weber HH, Beck E, Linnhoff A, Ukena D: Efficacy and safety of ciclesonide compared with budesonide in asthma patients: a randomized 12-week study [abstract]. American Thoracic Society 99th International Conference 2003:C105.
33. Hansel T, Engelstatter R, Benezet O, Kafe H, Ponitz HH, Cheung D, Barnes PJ: Once daily ciclesonide (80ug or 320ug) is equally effective as budesonide 200ug given twice daily: a 12 week study in asthma patients [Abstract]. European Respiratory Journal 2003, 22:.
34. Fardon TC, Lee DK, Gray RD, Currie GP, Haggart K, Bates CE, Lipworth BJ: Effects of hydrofluoralkane formulations of ciclesonide 320µg once daily versus fluticasone propionate 220µg twice daily on methacholine hyperresponsiveness in mild-to-moderate persistent asthma [Abstract]. Journal of Allergy and Clinical Immunology 2004, 113:S119.
35. Pauwels R, Derom E, Van DVV, Marissens S, Vincken W: Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and PC20 for adenosine in asthma patients [abstract]. American Journal of Respiratory and Critical Care Medicine 2002, 165:A768.
36. Derom E, Van DVV, Marissens S, Vincken W, Pauwels RA: Efficacy and systemic effects of ciclesonide and fluticasone in asthma patients. European Respiratory Journal 2001, 18:147s.